Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Newer Anticonvulsants for the Treatment of Status Epilepticus
Salia Farrokh, John J. Bon, Michael Erdman, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2019) Vol. 39, Iss. 3, pp. 297-316
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management
Batool Kirmani, Katherine Au, Lena Ayari, et al.
Aging and Disease (2021) Vol. 12, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 31
Quinazoline: An update on current status against convulsions
Rameshwar S. Cheke, Sachin D. Shinde, Jaya P. Ambhore, et al.
Journal of Molecular Structure (2021) Vol. 1248, pp. 131384-131384
Closed Access | Times Cited: 25
Status epilepticus in older adults: A critical review
Matthew R. Woodward, Michael Armahizer, Tina I. Wang, et al.
Epilepsia (2025)
Open Access
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy
Arne Reimers, Hanna Ljung
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 8, pp. 909-915
Open Access | Times Cited: 25
Prevention, Treatment, and Monitoring of Seizures in the Intensive Care Unit
Micheal Strein, John Holton-Burke, LaTangela R. Smith, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 8, pp. 1177-1177
Open Access | Times Cited: 23
Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review
Siew‐Na Lim, Tony Wu, Wei-En Johnny Tseng, et al.
Journal of Neurology (2021) Vol. 268, Iss. 10, pp. 3744-3757
Closed Access | Times Cited: 18
Perampanel in achieving status epilepticus cessation: A systematic review
Dominique Q. Perez, Adrian I. Espiritu, Roland Dominic G. Jamora
Epilepsy & Behavior (2022) Vol. 128, pp. 108583-108583
Closed Access | Times Cited: 13
Status epilepticus - time is brain and treatment considerations
Caroline Der‐Nigoghossian, Clio Rubiños, Ayham Alkhachroum, et al.
Current Opinion in Critical Care (2019) Vol. 25, Iss. 6, pp. 638-646
Open Access | Times Cited: 21
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
Laurent M. Willems, Sebastian Bauer, Kolja Jahnke, et al.
CNS Drugs (2020) Vol. 34, Iss. 8, pp. 801-826
Open Access | Times Cited: 19
The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
Te‐Yu Hung, Sheng‐Nan Wu, Chin‐Wei Huang
Biomedicines (2021) Vol. 9, Iss. 4, pp. 369-369
Open Access | Times Cited: 17
Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus
Pablo Bravo, Aparna Vaddiparti, Lawrence J. Hirsch
Drugs (2021) Vol. 81, Iss. 7, pp. 749-770
Closed Access | Times Cited: 15
Eslicarbazepine acetate for the treatment of status epilepticus
Yaroslav Winter, Katharina Sandner, Thomas Vieth, et al.
Epileptic Disorders (2023) Vol. 25, Iss. 2, pp. 142-149
Open Access | Times Cited: 5
The relationship of psychological, clinical and biological components in epilepsy
Н.Г. Токарева, С. С. Зыкова, V.S. Talismanov
E3S Web of Conferences (2020) Vol. 217, pp. 08006-08006
Open Access | Times Cited: 13
Stiripentol in the treatment of adults with focal epilepsy- a retrospective analysis
Lena Habermehl, Peter Mross, Kristina Krause, et al.
Seizure (2021) Vol. 88, pp. 7-11
Open Access | Times Cited: 12
Mechanism of action of antiepileptic drugs
Haider Ali, Naushad Ahmad Khan, Mirza Masroor Ali Beg, et al.
Elsevier eBooks (2022), pp. 177-193
Closed Access | Times Cited: 9
Rufinamide, a Triazole-Derived Antiepileptic Drug, Stimulates Ca2+-Activated K+ Currents While Inhibiting Voltage-Gated Na+ Currents
Ming‐Chi Lai, Sheng‐Nan Wu, Chin‐Wei Huang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13677-13677
Open Access | Times Cited: 9
Intravenous lacosamide for acute repetitive seizures and convulsive status epilepticus in critically ill children
Man‐Ru Hsiao, Tzu‐Cheng Tsai, Shao‐Hsuan Hsia, et al.
Epilepsia Open (2024)
Open Access | Times Cited: 1
Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature
Kristina Hubert, Susanne Knake, Sebastian Bauer, et al.
Epilepsy & Behavior (2020) Vol. 109, pp. 107139-107139
Closed Access | Times Cited: 7
Management of status epilepticus in patients with liver or kidney disease: a narrative review
Giovanni Mastroianni, Luigi Francesco Iannone, Roberta Roberti, et al.
Expert Review of Neurotherapeutics (2020) Vol. 21, Iss. 11, pp. 1251-1264
Closed Access | Times Cited: 6
Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study
Yaroslav Winter, Katharina Sandner, Thomas Vieth, et al.
CNS Drugs (2023) Vol. 37, Iss. 10, pp. 929-936
Open Access | Times Cited: 2
Acute Provoked Seizures—Work-Up and Management in Adults
Rana Moosavi, Christa B. Swisher
Seminars in Neurology (2020) Vol. 40, Iss. 06, pp. 595-605
Closed Access | Times Cited: 4
Status Epilepticus: An Update on Pharmacological Management
Sulaiman Almohaish, Eljim P. Tesoro, Gretchen M. Brophy
Seminars in Neurology (2024) Vol. 44, Iss. 03, pp. 324-332
Closed Access
Seizures in the Intensive Care Unit
Manuel Melo Bicchi, Kelsey Ladd, Ayham Alkhachroum
Springer eBooks (2024), pp. 93-112
Closed Access
Continuous Visual Focal Status Epilepticus as the Primary Presentation of NMDA-R and GAD65-R Autoimmune Epilepsy
Elma Paredes-Aragón, Héctor Eduardo Valdéz-Ruvalcaba, Andrea Santos‐Peyret, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 2
Pharmacologic Management of Status Epilepticus
Erin D. Wieruszewski, Caitlin S. Brown, Jonathan G. Leung, et al.
AACN Advanced Critical Care (2020) Vol. 31, Iss. 4, pp. 349-356
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top